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Abstract
Background: Severe acute pancreatitis (SAP) remains a potentially life-threatening disease. Gastrointestinal motility
disturbance such as intestinal ileus is seen in every case. By now, the mechanisms of pancreatitis-induced ileus are
largely unknown. The main purpose of the present study was to observe changes of nitric oxide synthase-
immunoreactive (NOS-IR) neurons in ileal myenteric ganglia in SAP rats with gastrointestinal dysmotility, trying to
explore underlying nervous mechanisms of pancreatitis-induced ileus.
Methods: Twenty Sprague Dawley rats were randomly divided into sham operated group and SAP group. SAP was
induced by retrograde cholangiopancreatic duct injection of 5% sodium taurocholate. Abdominal X-ray and
intestinal transit were performed to detect the existence of paralytic ileus and intestinal dysmotility. Pathological
damage of pancreas was evaluated. Double-immunolabeling was employed for the whole-mount preparations of
ileal myenteric ganglia. The morphology of NOS-IR neurons were observed and the percentage of NOS-IR neurons
was calculated based on the total Hu-immunoreactive neurons. Total RNA of ileum was extracted according to
Trizol reagent protocol. Neuronal NOS (nNOS) mRNA expression was evaluated by RT-PCR.
Results: The small intestinal transit index in the SAP group was significantly lower compared with the sham
operated group (29.21 ± 3.68% vs 52.48 ± 6.76%, P <0.01). The percentage of NOS-IR neurons in ileal myenteric
ganglia in the SAP group was significantly higher than that in the sham operated group (37.5 ± 12.28% vs 26.32 ±
16.15%, P <0.01). nNOS mRNA expression in ileum of SAP group was significantly higher than that in the sham
operated group (1.02 ± 0.10 vs 0.70 ± 0.06, P < 0.01).
Conclusions: The increased quantity of NOS-IR neurons in ileal myenteric ganglia and increased nNOS mRNA
expression may suggest nNOS over expression as one of the nervous mechanisms of gastrointestinal dysmotility in
SAP rat.
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Background
Severe acute pancreatitis (SAP) remains a potentially
life-threatening disease with a mortatity rate about
16.3% [1]. Forty to seventy percent of patients with pan-
creatic necrosis develop pancreatic infection leading to
the development of sepsis, multiple organ failure (MOF)
and eventual death [2]. Clinical evidence and animal
experimentation of SAP have demonstrated that gastro-
intestinal motility disturbances such as intestinal ileus
play a critical role on pancreatitis-associated sepsis and
multiple organ failure [2,3]. Intestinal dysmotility results
in gut barrier dysfunction, bacterial overgrowth and bac-
terial translocation from gut lumen. Enteric bacterial
flora is the main source of pancreatic infection in SAP.
In clinical practice and experimental SAP, therapies for
restoration of intestinal dysmotility using prokinetic
agents such as traditional Chinese medicine rhubarb can
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prevent bacterial translocation and attenuate sepsis in
SAP patients [4,5].
By now, the mechanisms of pancreatitis-induced ileus
are largely unknown. Experimental studies have revealed
that many factors are involved, such as gastrointestinal
hormones, neurotransmitters, overproduction of inflam-
matory mediators, tissue macrophage dysfunction, and
endotoxin [6-11]. Such factors are able to alter gastroin-
testinal motility by direct effect on smooth muscle cells
or indirectly by influencing the neuronal circuits
involved in peristalsis [6].
Nitric oxide (NO) is an importment nonadrenergic,
noncholinergic (NANC) neurotransmitter in the enteric
nervous system (ENS). It is generated from L-arginine
by neuronal NO synthase (nNOS/NOS-I). NO has a
potent inhibitory effect on the smooth muscle in several
regions of the gastrointestinal tract [12]. NO may also
act as a neuromodulator by facilitating or inhibiting the
release of other neurotransmitters within the same
nerve ending [13]. Also, there is evidence that NO
might act as a second messenger within smooth muscle
or interstitial cells of Cajal (ICC) [13,14].
The main purpose of the present study was to observe
changes of NOS-immunoreactive neurons in ileal myen-
teric ganglia and ileal nNOS mRNA expression in rat
SAP, trying to explore underlying nervous mechanisms
of pancreatitis-induced ileus. In this study, the bile duct
perfusion-induced pancreatitis model was employed.
The bile duct perfusion-induced pancreatitis model is a
well-established, reliable, and highly repeatable pancrea-
titis model with clinical relevance. Cholangiopancreatic
duct infusion with taurocholate is a well-established
SAP rat model that induces multiple organ failure invol-
ving the lung, kidney, liver, intestine, and brain [15].
Methods
Animals and experimental models
Twenty male Sprague-Dawley rats (180-220 g, from
Experimental Animal Center, Guilin Medical College)
were used in this study. All experiments were approved
by the Animal Ethics Committee, Guilin Medical Col-
lege. The rats were randomly divided into two groups: a
sham operated group (n = 10) and a SAP group (n =
10). General anesthesia was induced by an intraperito-
neal injection of 1 mg/kg of urethane. The abdomen
was then shaved and prepared with 5% povidone-iodine
solution. A midline incision was made. Duodenum and
pancreas were exposed. SAP was induced by injecting
5% sodium taurocholate solution (1 ml/kg, 0.1 ml/min)
retrogradely into the cholangiopancreatic duct using a
4.5 gauge needle. In the sham operated group, pancreas
was flipped several times without the duct puncture.
After the surgery, duodenum and pancreas was carefully
returned to the peritoneal cavity and the incision was
closed with continuous sutures. The animals were left to
recover for one hour and were then put into metallic
cages, one rat per cage, and food and water were not
allowed to access for 24 h.
Abdominal X-ray and small intestinal transit index
24 h after induction of pancreatitis, all rats were sub-
jected to abdominal X-ray examination for identification
of presence of gas and fluid in the the gut. For intestinal
transit test, 1.5 ml of 1% trypan blue solution was intra-
gastrically gavaged for each rat. 30 min later, rats were
sacrificed. The entire small intestine was removed under
tension-free state. The small intestinal transit index was
calculated as trypan blue containing segment length/
total length × 100%, as previously described [11].
H-E Staining
Pancreas was dissected and fixed overnight at room
temperature in a pH-neutral, phosphate-buffered, 10%
formaldehyde solution. The tissue was then embedded
in paraffin, sectioned at a thickness of 5 μm, stained
with hematoxylin and eosin, and coded before examina-
tion by a pathologist unaware of the specimen identity.
The severity of pancreatic damage was graded by the
pathologist using scoring criteria according to references
[16]. Briefly, H-E stained sections were graded in a
blinded fashion for the extent and severity of edema (0-
4), Hemorrhage and fat necrosis (0-4), inflammatory
infiltration (0-4) and acinar necrosis (0-4). The scores
for each histopathologic parameter were summed up,
leading to a minimum score of 0 and a maximal possi-
ble score of 16.
Double-immunolabeling study
From each rat, 1.5 cm segment of the ileum, 2 cm orally
to the ileocecal orifice, was collected. The segment was
placed in ice-cold Kreb’s solution (NaCl, 133.0; KCl, 4.7;
CaCl2.2 H2O, 2.5; MgCl2, 1.0; NaHCO3, 16.3; NaH2PO4,
1.4; glocose, 7.8, in mM), opened along the mesenteric
border, flushed with ice-cold Krebs and pinned tautly
on balsa wood with the mucosal surface down. Speci-
men was subsequently fixed in Stefanini’s solution (a
mixture of 2% paraformaldehyde and 0.2% picric acid in
phosphate buffer, pH 7.2) for 24 h at 4°C. Whole-mount
preparation of the myenteric ganglia were prepared by
peeling off the circular smooth muscle layer with fine
forceps. The double-immunolabeling study was done by
incubating the specimens in 10% normal goat serum
and 0.5% Triton X-100 in PBS for 30-60 min at room
temperature in order to block non-specific binding of
antibodies and to enhance penetration of the antibody.
Indirect immunofluorescence method was used for dou-
ble-immunolabeling. Table 1 summarizes the antibodies
used and their dilutions. In this study anti-Hu
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antibodies were used as general neuronal marker. Tissue
was incubated with primary antibodies at 4°C in a
humid chamber for 24 h. Each individual primary anti-
serum was applied separately. After washing in PBS (3 ×
10 min), the tissue was incubated for 45 min at room
temperature in a humid chamber, with secondary anti-
bodies of goat anti-rabbit-IgG tetramethyl rhodamine
isothiocyanate (TRITC)-labeled and goat anti-mouse-
IgG fluorescein isothiocynate (FITC)-labeled. After
washing in PBS (3 × 10 min), the tissue was mounted
on glass slides using phosphate-buffered glycerol (pH
8.2) and examined under an Olympus fluorescent
microscrope.
Quantitive analysis
The proportion of neurons labeled for NOS were esti-
mated by cell counting on preparations double immu-
nostained for NOS and Hu. The proportion of neurons
containing NOS were expressed as a percentage of Hu-
IR cells. The following protocol was used: starting from
one defined point of the preparation and moving across
the slide in a systematic way, at least 200 Hu-immunor-
eactive neurons from each whole mount were examined.
RT-PCR studies
From each rat, a 1-cm segment of the ileum, beginning
at 4 cm orally to the ileocecal orifice was collected. The
segment was immediately immersed and rinsed in ice-
cold Krebs solution. The procedures of total RNA extra-
tion were according to Trizol reagent protocol of manu-
facturer’s instructions (invitrogen, Life Technologies, Ca,
USA). Purified RNA was dissolved in water and the con-
centration measured by absorbance at 260 nm. RNA
quality was determined by running samples on 1.5%
agarose-formaldehyde gels stained with ethidium bro-
mide, and RNA concentration and purity were deter-
mined by optical density measurements at 260 and 280
nm. RNA samples were uniformly of high quality by
these standards.
The procedures of RT-PCR analysis were according to
the protocol of manufacturer’s instructions (Takara,
Dalian, China). First-strand cDNA was synthesized from
4 μg total RNA in a reaction buffer of 20 uL containing
5 × PrimeScriptTMBuffer 4 uL, PrimeScriptTMRT
Enzyme Mix | 1 uL, Oligo dT Primer 1 Ul, Random 6
mers 1 uL. The reaction mixture was incubated for 15
minutes at 37°C and then 5 seconds at 85°C. The primer
chosen for rat nNOS and b-actin were according to
references [17,18]. The sequences of sense and antisense
primers for rat nNOS and b-actin are listed in Table 2.
We subjected 25 μl of the RT-reaction mixture to an
one-tube coamplification of nNOS and b-actin as refer-
ence standard and internal control. The PCR amplifica-
tion protocol of nNOS was as followings: after an initial
denaturation at 94°C for 5 min, 35 cycles with 1 min of
denaturation at 95°C; 1 min of annealing at 53°C and 1
min of extension at 72°C on a thermal cycler. The PCR
amplification protocol of b-actin was as followings: after
an initial denaturation at 95°C for 3 min, 40 cycles with
45 s of denaturation at 94°C, 45 s of annealing at 56°C
and 45 s of extension at 72°C, the last cycle was fol-
lowed by an extension step at 72°C for 7 min. Amplified
products were electrophoresed on 2% agarose gel in
TBE buffer, stained with ethidium bromide, photo-
graphed under ultraviolet light, and quantified using
bandscan software. For semiquantification, the ratio of
the optical density of each PCR product and b-actin was
determined.
Data analysis and statistics
SPSS17.0 was employed for statistics. Values are
expressed as mean and median and range unless other-
wise stated. To compare the differences of Hu-IR neu-
rons and NOS-IR neurons between the sham operated
group and SAP group, an arcsine transformation of the
percentages was carried out before using Mann-Whint-
ney non-parametric U-test. P < 0.05 was considered as
statistically significant.
Results
Abdominal X-ray and small intestinal transit index
The intestines in SAP rats were significantly expanded
and abdominal X-ray film showed small intestinal gas
with niveau formation. Compared with the sham
Table 1 List of antibodies used in this study
Antibody Species Code Dilution Source
Primary antibodies
HuC/HuD Mouse A-21271 10 μg/mL Molecular Probes; Eugene, OR




Goat ZF-0316 1:200 Zhongshan Goldenbridge Biotechnology; Beijing, CHN
FITC-conjugated
goat anti-mouse IgG
Goat ZF-0312 1:100 Zhongshan Goldenbridge Biotechnology; Beijing, CHN
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operated group, small intestinal transit index in SAP
group was significantly lower (52.48 ± 6.76% vs 29.21 ±
3.68%, P <0.01). The results are demonstrated in Figure
1 and Table 3.
H-E Staining
All rats in the SAP group displayed pancreatic lesions
characteristic of interstitial edema, wide spread acinar
cell necrosis, neutrophil infiltration and haemorrhage. In
contrast, the pancreas was normal in the sham operated
group. The pancreatic pathological score of the SAP
group was significantly higher compared to the sham
operated group. The results are illustrated in Figure 2
and Table 3.
The proportion of NOS-IR neurons
Anti-Hu immunoreactivity was present in both nuclei
and somal cytoplasm of the myenteric neurons. Neuro-
nal processes were not stained by anti-Hu and the inter-
ganglionic connectives were not visible in the whole-
mount preparations. This absence of staining of nerve
fibres facilitated the identification of individual perikarya
and counting of the neurons, making anti-Hu an ideal
marker for quantitative analysis on the total numbers of
neurons [19,20]. The NOS-IR nerve cell bodies were
calculated as percentage of Hu-IR cells. NOS-IR staining
was detected in the cytoplasm and in the axons of the
neurons. Occasionally, some short lamellar processes
arising from the irregular somata profile could also be
seen.
In sham operated group (n = 10), a total of 105 myen-
teric ganglia were evaluated. 762 NOS-IR neurons
among the 2733 Hu-IR neurons were counted. In SAP
group (n = 10), a total of 112 myenteric ganglia were
evaluated. 1041 NOS-IR neurons among the 2763 Hu-
IR neurons were counted. Statistical analysis using
Mann-Whitney nonparametric test (carryed out an arc-
sine transformation of the percentages before using U-
test) showed that the percentage of NOS-IR neurons in
the SAP group was significantly higher compared to the
sham operated group (37.5 ± 12.28% vs 26.32 ± 16.15%,
P <0.01). While the Hu-IR neurons in the SAP group
did not significantly change in number compared to the
sham operated group (24 ± 14.5 vs 24 ± 11.5 per gang-
lion, P = 0.565). The results are summarized in Figure 3
and 4.
nNOS mRNA expression
The expression of nNOS mRNA significantly increased
in the SAP group compared to the sham operated group
(P < 0.05; Figure 5). The ratio of nNOS to b-actin
coamplified cDNAs was (1.02 ± 0.10) in the SAP group
and (0.70 ± 0.06) in the sham operated group.
Discussion
In this study, we demonstrated intestinal dysmotility and
ileus, by abdominal X-ray and small intestinal transit
test, in SAP rats. Double-immunolabeling of NOS and
Hu showed that the percentage of NOS-IR neurons in
Table 2 Sequences of sense and antisense primers for rat nNOS and b-actins
Enzyme and its sequence PCR Product, bp cDNA
Position
NCBI Refseq EMBL Accession No
nNOS
sense 5’-CCTCTCTGGCCACTAATG-3’ 335 331-354 NM-052799
antisense 5’-GACTACATCGTCAGCCTG-3’ 551-571
b-actin
Sense 5’-AACCCTAAGGCCAACCGTGAAAAG-3’ 241 3541-3558 V01217
antisense 5’-TCATGAGGTAGTCTGTCAGGT-3’ 3858-3875
EMBL: European Molecular Biology Laboratories.
Figure 1 Abdominal X-ray examination: Gas in intestine is
obvious in the SAP rat (B) compared to the sham operated rat
(A). X-ray film showed small intestinal gas with niveau formation (B).
Table 3 Summary of intestinal transit index and





sham operated group n = 10 52.48 ± 6.76 3.10 ± 0.45
SAP group n = 10 29.21 ± 3.68* 12.60 ± 1.80*
* P <0.01, as compared to sham operated group
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ileal myenteric ganglia in SAP group was significantly
higher compared to the sham operated group. nNOS
mRNA expression was significantly higher in the SAP
rats than in the sham operated rats. These findings
strongly suggest that gastrointestinal dysmotility in SAP
rats are related to the upregulation of NOS in ileal
myenteric ganglia. That may result in an increased pro-
duction of the inhibitory transmitter NO and possibly
also VIP, which finally results in a relaxation of smooth
muscle cells and intestinal paralysis.
ENS is a complex of intrinsic intestinal neurons
embedded in the gastrointestinal wall. It consists of neu-
rons organized into two main ganglionated plexuses:
myenteric ganglia and submucous ganglia. Myenteric
ganglia, located between the longitudinal and circular
muscle layers in the gastrointestinal wall, mainly regu-
lates gastrointestinal motility. The smooth muscle cells
in the circular and longitudinal muscle layers of
intestine are innervated by excitatory and inhibitory
motor neurons of ENS [21]. Vasoactive intestinal pep-
tide (VIP), NO, pituitary adenylate cyclase-activating
polypeptide, noradrenaline and opioids exert inhibitory
stimuli. Excitatory stimuli are exerted by tachykinins
(for instance substance P, SP), acetylcholine (Ach), and
serotonin (5-hydroxytryptamine, 5-HT). The ICC that
initiates basic electrical rhythm of gastrointestinal move-
ment also have receptors for the inhibitory transmitters
such as NO and VIP and for excitatory tachykinin trans-
mitters such as acetylcholine [22]. Alterations in the bal-
ance between inhibitory and excitatory
neurotransmitters within the ENS might contribute to
enteric motor dysfunction. Genetic primary enteric neu-
ropathic disorders and loss of inhibitory motor neurons
to smooth muscle cells bring about dysmotility. Such
situations have been demonstrated in the pathogenesis
of the following disorders: Hirschsprung’s disease,
Figure 2 Pancreatic H-E Staining: Pancreatic tissue displays normal in sham operated group (A). In SAP group acinar necrosis and
haemorrhage are observed (B). Magnification 20 ×.
Figure 3 Double-immunofluorescent staining of whole-mount preparations of myenteric ganglia: the sham operated group (A and B),
the SAP group(C and D); Hu-IR neurons (A and C), NOS-IR neurons (B and D); double labelling (A+B, C+D) for Hu (green) and NOS
(red). Magnification 200 ×.
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achalasia, irritable bowel syndrome, hypertrophic pyloric
stenosis, reflux oesophagitis, gastroparesis, chronic
intestinal pseudo-obstruction [21]. Alterations in the
balance of SP and VIP are associated with enteric motor
dysfunction after small bowel transplantation [23].
NO is a NANC neurotransmitter of ENS generated
from L-arginine by neuronal NO synthase (nNOS/NOS-
I) that has a potent inhibitory effect on the smooth
muscle in various regions of the gastrointestinal tract
[12]. NO may also act as a neuromodulator by facilitat-
ing or inhibiting the release of other neurotransmitters
within the same nerve ending [13]. There is also
evidence that NO might act as a second messenger
within smooth muscle or interstitial cells of Cajal (ICC)
[13,14].
Nervous mechanisms of pancreatitis-induced gastroin-
testinal dysmotility have been previously demonstrated
by other investigators. Mascolo and his colleagues [24]
showed that in acetic acid-induced mouse pancreatitis,
paralytic ileus and overactivity of cannabinoid CB1
receptors (CB1 receptors) of the enteric cholinergic/SP
neurons were observed. Overactivity of CB1 receptors
on the enteric cholinergic/SP neurons could lead to
reduced release of neurotransmitters of Ach and SP
with subsequent delayed motility. Liu and colleagues
[25] found that pancreatitis-associated ascitic fluid had
effects on the electrogastrointestinal arrhythmia in rats
and the mechanisms were related with the activation of
nNOS in jejunum myenteric plexus during acute pan-
creatitis. Our study demonstrated that in the SAP group
the percentage of NOS-IR neurons in ileal myenteric
ganglia was significantly higher and that nNOS mRNA
expression in ileum significantly increased. We hypothe-
size that the upregulation of NOS results in an
increased release of inhibitory transmitters such as NO
and alteration in the balance between inhibitory and
excitatory neurotransmitters.
Interestedly, Zhou and colleagues [26] reported that
the pathogenesis of the small intestinal paralysis in
acute necrotizing pancreatitis (ANP) may be related to
the deficiencies in ICC and nNOS neurons. The authors
observed damages of the interstitial cells of Cajal and
myenteric neurons causing ileus in ANP rats induced by
intraperitoneal injection of L-ornithine. The authors also
observed a reduced number of nNOS-IR neurons in the
myenteric ganglia. In Rakonczay’s rat models of L-
ornithine induced ANP [27], intraperitoneal injection of
L-ornithine at the dose of 4 to 6 g/kg killed the animals
within hours, and at the dose of 3 g/kg adhesions of
abdominal organs were observed. Those factors suggest
a toxicity of L-ornithine to cells not only on pancreas
but also on neurons of myenteric ganglia. The mechan-
ism underlying L-ornithine-induced pancreatitis is not
clear. A decrease in pancreatic polyamine levels is likely
to result in an inhibition of DNA and protein synthesis,
which will result in the death of acini [27]. It is possible
that inhibition of DNA and protein synthesis in the
myenteric neurons and direct toxicity of L-ornithine to
the myenteric neurons result in a decrease of nNOS-IR
neurons. Therefore, different models of acute pancreati-
tis will result in different changes of myenteric neurons.
In our research, we employed the bile duct perfusion-
induced pancreatitis model. The mechanism of the bile
duct perfusion-induced pancreatitis is attributed to the
infusion of exogenous substance, for example taurocho-
late, and the hydrostatic pressure associated with the
Figure 4 Compared with sham operated group, the NOS-IR
neurons in SAP group increased significantly (P = 0.00 <0.01),
while the Hu-IR neurons did not significantly change in
number between two groups (P = 0.565). Plots display median
(horizontal bars), 25th and 75 th percentiles (lower and upper
limits of boxes), and lowest and highest valves excluding
outers (error bars).
Figure 5 Epressions of nNOS mRNA in ileum: nNOS of the
sham operated group (A), nNOS of the SAP group (B), b-actin
of the sham operated group (C), b-actin of the SAP group (D).
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infusion [15]. Taurocholate solution is injected into the
the cholangiopancreatic duct and has no direct toxicity
to the neurons of myenteric ganglia, as the results in
our study showed that the Hu-IR neurons in the SAP
group did not significantly change in number compared
to the sham operated group.
Enteric neuronal plasticity is an essential adaptive
response to various injuries or functional changes within
the gastrointestinal tract. It is a complex process invol-
ving alterations in neuronal excitability, neurotransmit-
ter expression and/or structural rearrangements. These
changes can occur transiently in response to an acute
stimulus or become permanently encrypted into the
enteric neural circuitry following severe injury or a
chronic pathological process [28,29]. Evidences of an
altered expression of neuropeptides within the enteric
neurons in response to neuronal injury, e.g., axotomy,
colchicine treatment, isolation and culturing or in
response to changes in intestinal activity, are steadily
amounting [30,31]. The upregulation of NOS in our
study most likely represents a neuronal plasticity reac-
tion to SAP.
In our previous study, changes in the numbers of
NOS and VIP expressing neurons were investigated in
cultured submucous neurons from rat colon in vitro
[32]. The results showed that the proportion of NOS-IR
neurons was increased while the proportion of VIP-IR
neurons remained unchanged. The possible explanation
for this phenomenon is that the VIP-IR neurons may
have the ability to synthesize NOS when cultured in
vitro. This study suggested an enteric neuron plasticity
in given circumstance.
Indeed, ENS is a potential target for pharmacological
treatment of gut motor disorders. The targets are
numerous, such as the excitatory and inhibitory motor
neurones, as well as sensory neurons [21]. Seerden et al
[6] reported that tegaserod, a 5-HT4 receptor agonist,
had a therapeutic benefit in the treatment of pancreati-
tis-induced ileus. Cerulein, a potent CCK-like decapep-
tide, activates CCK receptors on enteric neurons and
stimulates small bowel motility by releasing excitatory
transmitters such as Ach and SP. The pronounced pro-
kinetic effect of clinically used doses of cerulein (0.15-
0.3 μg/kg per day) has been confirmed in an experimen-
tal setting [33]. Therefore, inhibition of upregulated
nNOS mRNA expression using some potential reagents
may be a pharmacotherapeutic way to restore the gas-
trointestinal dysmotility occurring in SAP.
Conclusions
This study provides with the first evidence of NOS
upregulation in ileal myenteric ganglia in rat SAP
induced by bile duct perfusion of taurocholate. Gastro-
intestinal dysmotility was demonstrated in this SAP
model by the observation of small intestinal gas with the
niveau formation on abdominal X-ray and the lower
small intestinal transit index. These findings strongly
suggest that gastrointestinal dysmotility in SAP is related
to the upregulation of NOS in ileal myenteric ganglia, as
NOS is a rate-limiting enzyme of NO production. How-
ever, many factors in SAP situation are to be clarified,
for example, which neurons are now expressing NOS
after SAP and how do the excitatory motor neurons act
after NOS upregulation in SAP.
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